Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Not all patients with depression respond to medication. Two recently published studies provide additional information on how an alternative treatment, transcranial magnetic stimulation (TMS), could be ...

Transcranial magnetic stimulation (TMS) is a procedure to treat treatment-resistant major depressive disorder. During the treatment, our specialists will place an electromagnetic coil against your ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...

Paul Fitzgerald is a founder of TMS Clinics Australia / Monarch Mental Health Group which provides rTMS therapy through 21 clinics in three states of Australia. He has received grant funding from the ...

Not only is depression a debilitating disease, but it is also widespread. Approximately 20 million adult Americans experience at least one episode of depression per year. One promising treatment for ...

Awake craniotomy remains at the forefront of neurosurgical innovation, allowing for the resection of brain tumours adjacent to critical functional areas while minimising neurological deficits. This ...

Angela Myers is a freelance writer covering mental health, wellness and nutrition. She’s also conducted award-winning research on how to better communicate about sexual violence prevention and mental ...